Susan Loring

Array ( [id] => 3723118 [patent_doc_number] => 05670150 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'Non-depleting CD4-specific monoclonal antibodies for the treatment of insulin-dependent diabetes mellitus (IDDM)' [patent_app_type] => 1 [patent_app_number] => 8/436843 [patent_app_country] => US [patent_app_date] => 1995-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2935 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670150.pdf [firstpage_image] =>[orig_patent_app_number] => 436843 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3799861 [patent_doc_number] => 05830469 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Fas antagonists and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/429499 [patent_app_country] => US [patent_app_date] => 1995-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 14 [patent_no_of_words] => 18251 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830469.pdf [firstpage_image] =>[orig_patent_app_number] => 429499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3696463 [patent_doc_number] => 05677182 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Cleavage site blocking antibody to prohormone proteins and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/424243 [patent_app_country] => US [patent_app_date] => 1995-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10799 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677182.pdf [firstpage_image] =>[orig_patent_app_number] => 424243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3666741 [patent_doc_number] => 05668253 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-16 [patent_title] => 'Peptide having antigenic properties similar to \"a \"determinant of hepatitis B surface antigen' [patent_app_type] => 1 [patent_app_number] => 8/416962 [patent_app_country] => US [patent_app_date] => 1995-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 13220 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/668/05668253.pdf [firstpage_image] =>[orig_patent_app_number] => 416962 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3664142 [patent_doc_number] => 05597726 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-28 [patent_title] => 'Monoclonal antibodies reactive with a human atheroma associated antigen' [patent_app_type] => 1 [patent_app_number] => 8/413738 [patent_app_country] => US [patent_app_date] => 1995-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9594 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/597/05597726.pdf [firstpage_image] =>[orig_patent_app_number] => 413738 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3711855 [patent_doc_number] => 05616321 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-01 [patent_title] => 'Method of treating bacterial meningitis with anti-tumor necrosis factor antibody' [patent_app_type] => 1 [patent_app_number] => 8/410006 [patent_app_country] => US [patent_app_date] => 1995-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2052 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/616/05616321.pdf [firstpage_image] =>[orig_patent_app_number] => 410006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3874018 [patent_doc_number] => 05747293 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-05 [patent_title] => 'Intimin-like proteins of E. coli' [patent_app_type] => 1 [patent_app_number] => 8/409452 [patent_app_country] => US [patent_app_date] => 1995-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3034 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/747/05747293.pdf [firstpage_image] =>[orig_patent_app_number] => 409452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3700235 [patent_doc_number] => 05677426 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Anti-IL-8 antibody fragments' [patent_app_type] => 1 [patent_app_number] => 8/398613 [patent_app_country] => US [patent_app_date] => 1995-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 40 [patent_no_of_words] => 18058 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677426.pdf [firstpage_image] =>[orig_patent_app_number] => 398613 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726485 [patent_doc_number] => 05702946 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-30 [patent_title] => 'Anti-IL-8 monoclonal antibodies for treatment of inflammatory disorders' [patent_app_type] => 1 [patent_app_number] => 8/398611 [patent_app_country] => US [patent_app_date] => 1995-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 40 [patent_no_of_words] => 17929 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/702/05702946.pdf [firstpage_image] =>[orig_patent_app_number] => 398611 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3837304 [patent_doc_number] => 05707622 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-13 [patent_title] => 'Methods for treating ulcerative colitis' [patent_app_type] => 1 [patent_app_number] => 8/396851 [patent_app_country] => US [patent_app_date] => 1995-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 40 [patent_no_of_words] => 18088 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/707/05707622.pdf [firstpage_image] =>[orig_patent_app_number] => 396851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623028 [patent_doc_number] => 05686070 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Methods for treating bacterial pneumonia' [patent_app_type] => 1 [patent_app_number] => 8/398612 [patent_app_country] => US [patent_app_date] => 1995-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 40 [patent_no_of_words] => 18105 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686070.pdf [firstpage_image] =>[orig_patent_app_number] => 398612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3585241 [patent_doc_number] => 05552286 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-03 [patent_title] => 'Hybridoma cell lines and their monoclonal antibodies to human pluripotent granulocyte colony stimulating factor' [patent_app_type] => 1 [patent_app_number] => 8/382942 [patent_app_country] => US [patent_app_date] => 1995-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6507 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/552/05552286.pdf [firstpage_image] =>[orig_patent_app_number] => 382942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3571949 [patent_doc_number] => 05523085 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-06-04 [patent_title] => 'Monoclonal antibody in destruction of small cell lung carcinoma' [patent_app_type] => 1 [patent_app_number] => 8/378890 [patent_app_country] => US [patent_app_date] => 1995-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 4691 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/523/05523085.pdf [firstpage_image] =>[orig_patent_app_number] => 378890 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3842837 [patent_doc_number] => 05766591 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Methods and compositions useful for inhibition of angiogenesis' [patent_app_type] => 1 [patent_app_number] => 8/366665 [patent_app_country] => US [patent_app_date] => 1994-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 60 [patent_no_of_words] => 27481 [patent_no_of_claims] => 114 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766591.pdf [firstpage_image] =>[orig_patent_app_number] => 366665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3682914 [patent_doc_number] => 05662905 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Monoclonal antibody compositions cross-reactive and cross-protective against P. aeruginosa serotypes' [patent_app_type] => 1 [patent_app_number] => 8/366204 [patent_app_country] => US [patent_app_date] => 1994-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12122 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/662/05662905.pdf [firstpage_image] =>[orig_patent_app_number] => 366204 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4057867 [patent_doc_number] => 05866140 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Type I surface antigen associated with staphylococcus epidermidis' [patent_app_type] => 1 [patent_app_number] => 8/361821 [patent_app_country] => US [patent_app_date] => 1994-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5546 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866140.pdf [firstpage_image] =>[orig_patent_app_number] => 361821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3803373 [patent_doc_number] => 05830710 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease' [patent_app_type] => 1 [patent_app_number] => 8/353485 [patent_app_country] => US [patent_app_date] => 1994-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19826 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830710.pdf [firstpage_image] =>[orig_patent_app_number] => 353485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3586017 [patent_doc_number] => 05496549 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-03-05 [patent_title] => 'Bispecific monoclonal antibodies, thrombolytic agent and method of cell lysis' [patent_app_type] => 1 [patent_app_number] => 8/350497 [patent_app_country] => US [patent_app_date] => 1994-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 10945 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/496/05496549.pdf [firstpage_image] =>[orig_patent_app_number] => 350497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3989003 [patent_doc_number] => 05919453 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon' [patent_app_type] => 1 [patent_app_number] => 8/307588 [patent_app_country] => US [patent_app_date] => 1994-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 8598 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919453.pdf [firstpage_image] =>[orig_patent_app_number] => 307588 [rel_patent_id] =>[rel_patent_doc_number] =>)